STD Panel

Positive results for this test are reported to the CDC.

Fasting Required: No

Specimen: Blood and Urine. The patient should not have urinated for at least one hour prior to specimen collection. Female patients should not cleanse the labial area prior to providing the specimen.

Results: 7-10 business days
Note: Result turnaround times are an estimate and are not guaranteed. Our reference lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.

Description:
Chlamydia & Gonorrhea are both extremely common STD's that can infect both men and women. Almost 75% of female infections and 50% of male infections do not have symptoms. A pregnant woman with chlamydia or gonorrhea can pass the infection to her baby during childbirth.

This is a non-treponemal screening test for Syphilis. False positive results may occur due to systemic lupus erythematosus, leprosy, brucellosis, atypical pneumonia, typhus, yaws, pinta, or pregnancy. Monitoring of RPR is helpful in assessing effectiveness of therapy. If RPR screen is reactive, RPR Titer and Fluorescent Treponemal Antibody (FTA) Confirmatory testing will be performed.

Genital Herpes is generally caused by herpes simplex virus 2 (HSV-2). The herpes simplex virus is transmitted by direct contact with a sore or the body fluid of an infected individual.

Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningo-encephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients.

Includes:
Chlamydia trachomatis
Neisseria gonorrhoeae
Syphilis
Herpes Simplex Virus (HSV) Type 2-Specific Antibodies, IgG